These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8397997)

  • 1. Effects of enalaprilat on hemodynamics and ventricular activation duration in hypertensive patients with left ventricular hypertrophy: clinical evidence of improved excitation-contraction coupling with angiotensin converting enzyme inhibition in human hypertension.
    González-Fernández RA; Altieri PI; Jiménez R; Lastra J; Meléndez JR; Martínez-Toro JA; Banchs HL
    Am J Hypertens; 1993 Jul; 6(7 Pt 1):570-8. PubMed ID: 8397997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in cardiac conduction velocity delay by angiotensin converting enzyme inhibition in hypertensive patients with left ventricular hypertrophy. Detection by signal averaged electrocardiography.
    González-Fernández RA; Altieri PI; Fernández-Martínez J; Lugo JE
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):896-9. PubMed ID: 1337458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy.
    Haber HL; Powers ER; Gimple LW; Wu CC; Subbiah K; Johnson WH; Feldman MD
    Circulation; 1994 Jun; 89(6):2616-25. PubMed ID: 8205673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
    Friedrich SP; Lorell BH; Rousseau MF; Hayashida W; Hess OM; Douglas PS; Gordon S; Keighley CS; Benedict C; Krayenbuehl HP
    Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients.
    Boldt J; Schindler E; Wollbrück M; Görlach G; Hempelmann G
    J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):44-9. PubMed ID: 7718754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute angiotensin converting enzyme inhibition on left ventricular filling in patients with congestive heart failure. Relation to right ventricular volumes.
    Konstam MA; Kronenberg MW; Udelson JE; Metherall J; Dolan N; Edens TR; Howe DM; Yusuf S; Youngblood M; Toltsis H
    Circulation; 1990 Feb; 81(2 Suppl):III115-22. PubMed ID: 2153478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
    Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
    Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary actions of intravenously administered enalaprilat in trauma patients.
    Boldt J; Menges T; Wollbrück M; Hammermann H; Hempelmann G
    Crit Care Med; 1994 Jun; 22(6):960-4. PubMed ID: 8205828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased adrenergic response in hypertensive patients without left ventricular hypertrophy.
    Sugishita Y; Iida K; Fujieda K; Yukisada K
    Clin Cardiol; 1994 Feb; 17(2):71-6. PubMed ID: 8162629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalaprilat improves the impaired left ventricular pump function during exercise in hypertensives with coronary microangiopathy and with coronary artery disease.
    Franz I; Tönnesmann U; Schaupp S; van der Meyden J
    Kidney Blood Press Res; 1998; 21(6):452-8. PubMed ID: 9933831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
    Evans MA; Burnett JC; Redfield MM
    J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalaprilat in acute intractable heart failure after myocardial infarction: a prospective, consecutive sample, before-after trial.
    Tohmo H; Karanko M; Korpilahti K; Scheinin M; Viinamäki O; Neuvonen P
    Crit Care Med; 1994 Jun; 22(6):965-73. PubMed ID: 8205829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility.
    Sumimoto T; Ochi T; Ito T; Joh T; Muneta S; Hiwada K
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):27-32. PubMed ID: 9140674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.